ADRIAN ARYA
PHOENIX, AZ NPI 1477522340
Browse related groups: AZ AERIN MEDICAL INC. All categories
General Payments — all program years on this page
$1,580.01
- Category: General Payments
- Program years: PY2018–2024
- Record count: 59
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $230.27 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $230.27 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| AERIN MEDICAL INC. | $64.10 | 2 |
| GlaxoSmithKline, LLC. | $56.30 | 2 |
| Regeneron Pharmaceuticals, Inc. | $38.70 | 1 |
| GENZYME CORPORATION | $26.89 | 1 |
| BAXTER HEALTHCARE | $25.80 | 1 |
| OptiNose US, Inc. | $18.48 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1114396172 | Regeneron Pharmaceuticals, Inc. | $38.70 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116417556 | GlaxoSmithKline, LLC. | $32.64 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1116455583 | GlaxoSmithKline, LLC. | $23.66 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1118287628 | Baxter Healthcare | $25.80 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139661654 | GENZYME CORPORATION | $26.89 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1142167372 | Optinose US, Inc. | $18.48 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144647390 | AERIN MEDICAL INC. | $28.06 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144653238 | AERIN MEDICAL INC. | $36.04 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.